European Antibody Congress 2012 - list of video presentations & downloads

 
Show presentation icon

Chairman’s opening remarks

Dr Alain Beck at European Antibody Congress 2012
  • › Dr Alain Beck, Head of Physico-Chemistry Department, Centre d'Immunologie Pierre Fabre
Show presentation icon

Biobetter antibodies in oncology in clinical development

Dr Steffen Goletz at European Antibody Congress 2012
  • › Dr Steffen Goletz, Founder, CEO and CSO, Glycotope
Show presentation icon

Biopharmaceutical Characterization – mass spectrometric solutions for challenging analysis

Dr Catherine Evans at European Antibody Congress 2012
  • › Dr Catherine Evans, Business Development Manager Europe (Biopharma), Bruker Daltonics
Show presentation icon

Function-led antibody drug discovery: Solving the target deconvolution bottleneck

Jim Freeth at European Antibody Congress 2012
  • › Jim Freeth, Associate, Retrogenix Ltd
Show presentation icon

Fully human, better behaved antibody drugs

Dr Robert Burns at European Antibody Congress 2012
  • › Dr Robert Burns, Chief Executive Officer, 4-Antibody
Show presentation icon

Novartis Predictive tools for stabilization of therapeutic proteins

Dr Bernhard Helk at European Antibody Congress 2012
  • › Dr Bernhard Helk, Global Executive Director, Technology Development, Novartis
Show presentation icon

Epitope characterization and crystal structure of GA101 provide insight into mechanism of action

Dr Christian Klein at European Antibody Congress 2012
  • › Dr Christian Klein, Head Oncology Programs, Discovery Oncology, DTA Pharma Research and Early Development (PRED), Roche Glycart AG
Show presentation icon

Free or total therapeutic monoclonal antibody concentration monitoring

Dr Bing Kuang at European Antibody Congress 2012
  • › Dr Bing Kuang, Senior Principal Scientist, Pfizer
Show presentation icon

MeMo®, a Transgenic Mouse for the Discovery of Innovative Human Antibody Therapeutics

Dr Ton Logtenberg at European Antibody Congress 2012
  • › Dr Ton Logtenberg, CEO, Merus
Show presentation icon

Antibody characterization using unique enzymes in combination with mass spectrometry analysis

Dr Sarah Fredriksson at European Antibody Congress 2012
  • › Dr Sarah Fredriksson, Chief Executive Officer, Genovis
Show presentation icon

Novel Systematic Approach for the Discovery of New Antibody Targets

Dr Anat Cohen-Dayag at European Antibody Congress 2012
  • › Dr Anat Cohen-Dayag, President and CEO, Compugen
Show presentation icon

Antibody therapeutics development - state of the art

Dr Janice Reichert at European Antibody Congress 2012
  • › Dr Janice Reichert, Research Assistant Professor, Tufts Center for the Study of Drug Development
Show presentation icon

Novel antibody therapy Approach in Multiple Sclerosis and Schizophrenia

Dr Herve Perron at European Antibody Congress 2012
  • › Dr Herve Perron, Chief Scientific Officer, GeNeuro
Show presentation icon

Sensitivity and resistance to EGF-R inhibitors: approaches to enhance the efficacy of EGF-R antibodies

Prof Thomas Valerius at European Antibody Congress 2012
  • › Prof Thomas Valerius, Division of Stem Cell Transplantation and Immunotherapy, Christian-Albrechts University
Show presentation icon

CLIPS Technology meets GPCR: A New peptide based strategy for the generation of monoclonal Antibodies against GPCR’s

Dr Klaus Schwamborn at European Antibody Congress 2012
  • › Dr Klaus Schwamborn, Chief Development Officer, Pepscan Therapeutics
Show presentation icon

The VIVA|SCREEN platform: a high throughput single B lymphocytes screening technology for the rapid discovery and production of fully human antigen-specific monoclonal antibodies

Dr Majid Mehtali at European Antibody Congress 2012
  • › Dr Majid Mehtali, Managing Director and Chief Scientific Officer, Vivalis
Show presentation icon

Tetraspanin CD151 as a target for antibody-based cancer immunotherapy

Dr Jean-Francois Haeuw at European Antibody Congress 2012
  • › Dr Jean-Francois Haeuw, Head of Biochemistry Department, Centre d’Immunologie Pierre Fabre
Show presentation icon

Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier

Dr Lois Lampson at European Antibody Congress 2012
  • › Dr Lois Lampson, Associate Professor of Neurosurgery, Brigham and Women's Hospital & Harvard Medical School
Show presentation icon

515H7 mAb, a new monoclonal antibody which blocks SDF-1/CXCR4 signaling for cancer therapy

Dr Christine Klinguer-Hamour at European Antibody Congress 2012
  • › Dr Christine Klinguer-Hamour, Oncology Project Leader, Centre d’Immunologie Pierre Fabre
Show presentation icon

Novel Development in immunotherapy and prophylaxis against influenza A Groups I and II

Dr Robert Friesen at European Antibody Congress 2012
  • › Dr Robert Friesen, VP Preclinical and Clinical Research, Crucell
Show presentation icon

Applying Tag-lite® to therapeutic antibody screening and characterization: A review of recent findings

Mr Stephane Martinez at European Antibody Congress 2012
  • › Mr Stephane Martinez, Product Manager, Biotherapeutics, Cisbio Bioassays
Show presentation icon

Human monoclonal antibodies as adjunct therapies in infectious disease

Dr Michael Rudolf at European Antibody Congress 2012
  • › Dr Michael Rudolf, Chief Scientific Officer, Kenta Biotech AG

 

 

 

Download MAbs Meeting Reports 

2011 Meeting Report - download it here

2010 Meeting Report - download it here

2009 Meeting Report - download it here
 

Sponsors
Gold Sponsor
AbD Serotec at European Antibody Congress 2012
Silver Sponsor
Catalent Pharma Solutions at European Antibody Congress 2012
Associate Sponsor
TECOmedical at European Antibody Congress 2012
Associate Sponsor
MABgene at European Antibody Congress 2012
Associate Sponsor
Vivalis at European Antibody Congress 2012
Associate Sponsor
Cisbio Bioassays at European Antibody Congress 2012
Associate Sponsor
Clean Cells at European Antibody Congress 2012
Associate Sponsor
4-Antibody at European Antibody Congress 2012
Associate Sponsor
Crucell Holland BV at European Antibody Congress 2012
Associate Sponsor
Genovis AB at European Antibody Congress 2012
Associate Sponsor
Kenta Biotech AG at European Antibody Congress 2012